vimarsana.com

Page 4 - அதிகபட்சம் சுகாதாரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stocks to Watch: UCO Bank, Max Healthcare, Gulf Oil, Sun Pharma, AstraZeneca Pharma among others

Stocks to Watch: UCO Bank, Max Healthcare, Gulf Oil, Sun Pharma, AstraZeneca Pharma among others
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Max Healthcare Q4 results: PAT rises 31% to Rs 70 cr

Max Healthcare Q4 results: PAT rises 31% to Rs 70 cr SECTIONS Last Updated: May 28, 2021, 05:49 PM IST Share Synopsis Revenue from operations stood at Rs 801.86 crore for the quarter under review. It was Rs 247.86 crore in the same period a year ago. The company had posted a PAT of Rs 53.15 crore for the corresponding period of the previous fiscal year, Max Healthcare Institute said in a filing to BSE. Related NEW DELHI: Max Healthcare on Friday reported 31.11 per cent rise in consolidated profit after tax (PAT) at Rs 69.69 crore for the quarter ended March 31, 2021. The company had posted a PAT of Rs 53.15 crore for the corresponding period of the previous fiscal year, Max Healthcare Institute said in a filing to BSE.

Max Healthcare suffers Rs 137 55 cr loss in FY21 despite revenue growth

Results: Max Healthcare Q4 PAT up 31% to Rs 70 crore

Results: Max Healthcare Q4 PAT up 31% to Rs 70 crore Pexels Max Healthcare on Friday reported 31.11 per cent rise in consolidated profit after tax (PAT) at Rs 69.69 crore for the quarter ended March 31, 2021. The company had posted a PAT of Rs 53.15 crore for the corresponding period of the previous fiscal year, Max Healthcare Institute said in a filing to BSE. Revenue from operations stood at Rs 801.86 crore for the quarter under review. It was Rs 247.86 crore in the same period a year ago, it added. For the fiscal year ended March this year, the company posted a loss of Rs 137.55 crore as against a PAT of Rs 58.99 crore in 2019-20, the filing said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.